SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
/PRNewswire/ -- SoniVie Ltd. ("SoniVie" or the "Company"), a medical device company developing a proprietary solution to treat hypertension, announced today...
Stay updated with breaking news from Andera Croissance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- SoniVie Ltd. ("SoniVie" or the "Company"), a medical device company developing a proprietary solution to treat hypertension, announced today...
DGAP-News: Andera Partners / Key word(s): Personnel Andera Partners strengthens its Life Sciences team with a new partner 07.07.2022 / 10:15 The issuer is solely responsible for
Significant round will enable the Company to advance ICT01, its lead anti-butyrophilin 3A antibody, to completion of randomized Phase II trialsSeries C...
/PRNewswire/ -- Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for...
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension 08.06.2022 / 14:05 The issuer is solely responsible for the content of th...